Table 1. Total and subscale scores of the Uterine Fibroid Symptom – Quality of Life questionnaire before and after uterine fibroid embolization (n=60).
| UFS-QoL | Evaluation | Variation | p value* | |
|---|---|---|---|---|
| Pre-embolization | Post-embolization | |||
| Symptom severity | <0.001 | |||
| Median (Q1-Q3) | 68.8 (59.4-76.6) | 9.4 (3.1-31.3) | -53.1 (-71.9- -29.7) | |
| (Min-Máx) | 6.3-100.0 | 0.0-59.4 | -81.3-3.1 | |
| Concern | <0.001 | |||
| Median (Q1-Q3) | 25.0 (7.5-45.0) | 92.5 (80.0-100.0) | 60.0 (30.0-85.0) | |
| (Min-Máx) | 0.0-100.0 | 25.0-100.0 | -5.0-100.0 | |
| Activities | <0.001 | |||
| Median (Q1-Q3) | 42.9 (25.0-57.1) | 96.4 (85.7-100.0) | 50.0 (32.1-67.9) | |
| (Min-Máx) | 0.0-100.0 | 46.4-100.0 | -14.3-89.3 | |
| Energy/mood | <0.001 | |||
| Median (Q1-Q3) | 42.9 (26.8-57.1) | 96.4 (83.9-100.0) | 46.4 (30.4-67.9) | |
| (Min-Máx) | 0.0-96.4 | 35.7-100.0 | 3.6-92.9 | |
| Control | <0.001 | |||
| Median (Q1-Q3) | 40.0 (20.0-52.5) | 90.0 (75.0-100.0) | 50.0 (30.0-75.0) | |
| (Min-Máx) | 0.0-100.0 | 5.0-100.0 | 5.0-90.0 | |
| Self-awareness | <0.001 | |||
| Median (Q1-Q3) | 33.3 (16.7-50.0) | 91.7 (75.0-100.0) | 58.3 (25.0-66.7) | |
| (Min-Máx) | 0.0-100.0 | 25.0-100.0 | -8.3-100.0 | |
| Sexual function | <0.001 | |||
| Median (Q1-Q3) | 37.5 (25.0-50.0) | 100.0 (75.0-100.0) | 50.0 (25.0-75.0) | |
| (Min-Máx) | 0.0-100.0 | 50.0-100.0 | -12.5-100.0 | |
| Total score | <0.001 | |||
| Median (Q1-Q3) | 41.4 (22.0-50.0) | 92.2 (83.2-97.8) | 52.6 (30.2-73.3) | |
| (Min-Máx) | 0.0-97.4 | 45.7-100.0 | 1.7-87.9 | |
* Wilcoxon’s test.
UFS-QoL: Uterine Fibroid Symptom – Quality of Life questionnaire; Q1: first quartile; Q3: third quartile.